First Time Loading...
N

Nuoncology Labs Inc
OTC:NLAB

Watchlist Manager
Nuoncology Labs Inc
OTC:NLAB
Watchlist
Price: 297 USD Market Closed
Updated: May 20, 2024

P/E
Price to Earnings

-1 004 063.9
Current
-1 004 063.9
Median
20
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1 004 063.9
=
Market Cap
29.3B
/
Net Income
-29.2k
All Countries
All Countries
Close
Earnings Growth
US
N
Nuoncology Labs Inc
OTC:NLAB
Average P/E: 3 895.6
Negative Multiple: -1 004 063.9 		N/A
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -141 194.8 N/A
US
Music Licensing Inc
OTC:SONG
7 748.6
N/A
US
G
Gould Investors LP
OTC:GDVTZ
Not Available N/A
US
C
Carson Energy Development Corp
OTC:CDVM
Negative Multiple: -70 424.1 N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-12%
US
Liberty Bancshares Inc
OTC:LBSI
Not Available N/A
US
Ergo Science Corp
OTC:ERGN
Negative Multiple: -12 841.6 N/A
US
H
HK Graphene Technology Corp
OTC:HKGT
Negative Multiple: -33 104.9 N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
42.6
N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A

See Also

Summary
NLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
NLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NLAB stock valuation using valuation multiples.
Wall Street Estimates
NLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.